Lucid’s quarterly revenue increased 392 percent sequentially
Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4
Conference call and webcast to be held tomorrow, November 15th at 8:30 AM EST
NEW YORK, Nov. 14, 2023 /PRNewswire/ — PAVmed Inc. (NASDAQ: PAVM, PAVMZ) (“PAVmed” or the “Company”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) (“Lucid”) and Veris Health Inc. (“Veris”), and presented financial results for the Company for the three and nine months ended September 30, 2023.
Conference Call and Webcast
The webcast will take place on Wednesday, November 15, 2023, at 8:30 AM and is accessible in the investor relations…